-
2025-521035-37-00
5
2026-03-02
Immune system diseases
-
2024-511101-28-00
4
2026-02-24
Episodic Migraine
Chronic Migraine
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2025-522074-37-00
4
2026-02-19
Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension Associat
-
2024-516356-18-00
5
2026-02-17
Atherosclerotic cardiovascular disease (ASCVD)
-
2024-518777-34-00
5
2026-02-11
B7-H4-Selected Advanced/Metastatic Endometrial Cancer.
-
2025-522960-34-00
5
2026-02-09
Established cardiovascular disease
-
2025-521636-10-00
4
2026-02-04
Progressive Forms of Multiple Sclerosis (PMS)
-
2024-517413-33-00
4
2026-02-03
Idiopathic Parkinson's Disease
-
2025-522370-36-00
4
2026-02-02
Moderate to Severe Atopic Dermatitis
-
2025-521717-67-00
3
2026-01-29
Acute myeloid leukemia
-
2025-523612-37-00
3
2026-01-23
Parkinson's Disease and Apathy
-
2024-515023-11-00
5
2026-01-22
Metastatic Clear Cell Renal Cell Carcinoma
-
2025-522090-11-00
9
2026-01-22
Relapsed or Refractory Multiple Myeloma (RRMM)
-
2023-507879-21-00
4
2026-01-19
AML and MDS undergoing allogeneic Transplantation
-
2025-522683-32-00
5
2026-01-15
Early-Stage Parkinson’s Disease (PD)
-
2025-522631-34-00
5
2026-01-14
Osteoarthritis
-
2025-521684-12-00
4
2026-01-13
Hidradenitis Suppurativa
-
2024-518281-27-00
7
2026-01-09
Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer
-
2024-519494-19-00
5
2025-12-22
Nutritional and metabolic diseases
-
2024-512503-39-00
6
2025-12-19
Arm A (AML): Newly diagnosed de novo Acute myeloid leukemia (AML) or M
-
2025-521003-52-00
9
2025-12-19
HER2 Expressing Advanced Breast Cancer
-
2025-521155-23-00
4
2025-12-19
Pulmonary Arterial Hypertension
-
2022-500676-59-00
4
2025-12-18
EBV-positive nasopharyngeal carcinoma